Increased invasiveness of MMP-9-deficient tumors in two mouse models of neuroendocrine tumorigenesis

Abstract excerpt

Despite their apparent success in pre-clinical trials, metalloproteinase (MMP) inhibitors proved to be inefficacious in clinical settings. In an effort to understand the underlying causes of this unanticipated outcome, we modeled the consequences of long-term MMP inhibition by removing one of the major players in tumorigenesis, MMP9, in two complimentary mouse models of pancreatic neuroendocrine carcinogenesis:...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Coagulation, Bradykinin, Polyphosphates, and Angioedema
• Share to Peptidase Inhibition and Analysis
• Share to Protease and Inhibitor Mechanisms